Oncolytic Reovirus in Combination with Paclitaxel/Carboplatin in NSCLC Patients with Ras Activated Malignancies, Long Term Results

被引：0
|
作者：
Villalona, Miguel [1 ]
Lam, Elaine [1 ]
Otterson, Gregory [1 ]
Zhao, Weqiang [2 ]
Timmons, Matthew [3 ]
Subramaniam, Deepa [4 ]
Hade, Erin [5 ]
Bertino, Erin [5 ]
Chao, Bo [1 ]
Selvaggi, Giovanni [6 ]
Knopp, Michael [7 ]
Gill, George M. [6 ]
机构：
[1] Ohio State Univ, Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Pathol, Columbus, OH 43210 USA
[3] Ohio State Univ, Canc Ctr, Columbus, OH 43210 USA
[4] Georgetown Univ, Med Oncol, Washington, DC USA
[5] Ohio State Univ, Dept Med Informat, Ctr Biostat, Columbus, OH 43210 USA
[6] Oncolytics Inc, Clin Dev, Calgary, AB, Canada
[7] Ohio State Univ, Radiol, Columbus, OH 43210 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
reovirus; Kras activation; BRAF; long term survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI30.01
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [41] Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
    Jotte, Robert
    Cappuzzo, Federico
    Vynnychenko, Ihor
    Stroyakovskiy, Daniil
    Rodriguez-Abreu, Delvys
    Hussein, Maen
    Soo, Ross
    Conter, Henry J.
    Kozuki, Toshiyuki
    Huang, Kuan-Chieh
    Graupner, Vilma
    Sun, Shawn W.
    Hoang, Tien
    Jessop, Helen
    McCleland, Mark
    Ballinger, Marcus
    Sandler, Alan
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (08) : 1351 - 1360
  • [42] ABOUND.70+: Interim Quality of Life (QoL) Results of nab-Paclitaxel/Carboplatin Treatment of Elderly Patients With NSCLC
    Weiss, Jared
    Kim, Edward
    Amiri, Kathy
    Anderson, Eric
    Dakhil, Shaker
    Haggstrom, Daniel
    Jotte, Robert
    Konduri, Kartik
    Modiano, Manuel
    Ong, Teng
    Sanford, Alexandra
    Smith, David
    Socoteanu, Matei
    Goldman, Jonathan W.
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S911 - S912
  • [43] Safety and efficacy of AMG 655 in combination with paclitaxel and carboplatin (PC) in patients with advanced non-small cell lung cancer (NSCLC)
    Paz-Ares, L.
    Sanchez Torres, J. M.
    Diaz-Padilla, I.
    Links, M.
    Reguart, N.
    Boyer, M.
    Wiezorek, J.
    Sabin, T.
    Pan, Y.
    Van Meerbeeck, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] ABOUND.PS2 Interim Safety Results: nab-Paclitaxel/Carboplatin Followed by nab-Paclitaxel in NSCLC Patients with ECOG PS of 2
    Gajra, Ajeet
    Ali, Haythem
    Amiri, Katayoun I.
    Karim, Nagla A.
    Matrana, Marc R.
    Mulford, Deborah
    Ong, Teng J.
    Sanford, Alexandra
    Santos, Edgardo S.
    Socinski, Mark A.
    Spigel, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S274 - S274
  • [45] Long-Term Results of Adjuvant Chemotherapy in Completely Resected NSCLC Patients
    Wurstbauer, Karl
    Sedlmayer, Felix
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 404 - 405
  • [46] GYN 4: A phase I dose escalation and pharmacokinetic study of BIBF 1120 in combination with paclitaxel/carboplatin in patients with advanced gynecological malignancies
    Belau, A.
    Huober, J.
    Pfisterer, J.
    Wimberger, P.
    Loibl, S.
    Stopfer, P.
    Kaiser, R.
    Reichardt, V.
    du Bois, A.
    ONKOLOGIE, 2008, 31 : 105 - 105
  • [47] Neoadjuvant Weekly Carboplatin and Paclitaxel Followed by Radical Hysterectomy for Locally Advanced Cervical Cancer Long-Term Results
    Mori, Taisuke
    Hosokawa, Kenichi
    Sawada, Morio
    Kuroboshi, Haruo
    Tatsumi, Hiroshi
    Koshiba, Hisato
    Okubo, Tomoharu
    Kitawaki, Jo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (04) : 611 - 616
  • [48] Long-term survival of a patient with refractory advanced adrenocortical carcinoma after combination chemotherapy with paclitaxel and carboplatin plus mitotane
    Kobayakawa, Yuki
    Hamamoto, Shuzo
    Kamisawa, Hideyuki
    Okada, Shinsuke
    Taguchi, Kazumi
    Naiki, Taku
    Okada, Atsushi
    Tozawa, Keiichi
    Yasui, Takahiro
    IJU CASE REPORTS, 2022, 5 (04) : 288 - 292
  • [49] Pazopanib combination with paclitaxel and carboplatin in patients with advanced solid tumors and gynecological cancers: Results of two phase I studies
    Burris, Howard, III
    du Bois, Andreas
    Dowlati, Afshin
    Gainer, Shelby
    Park, JungWook
    Stutts, Melissa
    Dar, Mohammed
    Suttle, Ben
    Mitrica, Lone
    Tan, Antoinette R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [50] Randomized, open label, phase III trail of figitumamab in combination with pacilitaxel and carboplatin versus paclitaxel and carboplatin in patients wiht non-small cell lung cancer (NSCLC)
    Jassem, J.
    Langer, C. J.
    Karp, D. D.
    Mok, T.
    Benner, R. J.
    Green, S. J.
    Park, K.
    Novello, S.
    Strausz, J.
    Gualberto, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345